oxazolidin-2-one has been researched along with Staphylococcal Skin Infections in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (35.71) | 29.6817 |
| 2010's | 27 (64.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ALeryan, M; Delpech, P; Gemmell, C; Jones, B; Lang, S | 1 |
| Ariza, B; Cortés, JA; De la Rosa, ZR; Gualtero, S; Leal, AL; Montañes, AM; Ovalle, MV; Rodríguez, JY; Sussman, O; Torres, MDP | 1 |
| Bassetti, M; Carnelutti, A; Righi, E | 1 |
| Chhibber, S; Kaur, T | 1 |
| Bag, T; Kumar, N; Mandal, K; Moitra, S; Roy, A; Sen, S | 1 |
| Frimodt-Møller, N; Vingsbo Lundberg, C | 1 |
| Biswas, P; Capitano, B; Duane, TM; Joshi, M; Puzniak, LA | 1 |
| Barreto, JN; Huang, DB; Morrow, LE; Puzniak, LA | 1 |
| Biswas, P; Capitano, B; Lodise, TP; Puzniak, LA | 1 |
| Dumitrescu, O; Lina, G | 1 |
| Baguneid, M; Bassetti, M; Bouza, E; Dryden, M; Nathwani, D; Wilcox, M | 1 |
| Chambers, R; Charbonneau, C; Eckmann, C; Haider, S; Hajek, P; Lawson, W; Li, JZ; Macahilig, C; Nathwani, D; Simoneau, D; Solem, CT; Stephens, JM | 1 |
| Corey, R; Dumont, E; Jones, LS; Kurtinecz, M; Naderer, OJ; O'Riordan, WD; Zhu, JZ | 1 |
| Fang, E; Lodise, TP; Minassian, SL; Prokocimer, PG | 1 |
| Corey, GR; Das, AF; De Anda, C; Fang, E; Lodise, TP; Prokocimer, P; Shorr, AF | 1 |
| Abazia, DT; Marcus, A; Ross, J; Sachinwalla, E; Smolarz, BG | 1 |
| Esposito, S; Leone, S; Noviello, S | 1 |
| Drewelow, B; Haase, G; Klammt, S; Majcher-Peszynska, J; Mundkowski, R; Pietsch, A; Sass, M; Schareck, W | 1 |
| Bounthavong, M; Hsu, DI; Okamoto, MP | 1 |
| Abbanat, D; Bush, K; Fernandez, J; Goldschmidt, R; Hilliard, JJ; Macielag, MJ; Melton, J | 1 |
| Besnier, JM; De Cock, E; Dupon, M; Duttagupta, S; Guery, B; Levrat, F; Sorensen, S | 1 |
| Carson, RT; Friedman, M; Marton, JP; Menzin, J; Meyers, JL; Rothermel, CD | 1 |
| Dodds, TJ; Hawke, CI | 1 |
| Chambers, HF; Deshpande, LM; Diep, BA; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Bounthavong, M; Hsu, DI | 2 |
| Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J | 1 |
| Huang, DB; Itani, KM; Joseph, W; Lipsky, BA; Myers, DE; Paap, CM; Reisman, A; Weigelt, JA | 1 |
| Duane, TM; Huang, DB; Puzniak, LA; Weigelt, JA | 1 |
| Crandon, JL; Keel, RA; Nicolau, DP; Tessier, PR | 1 |
| Bartizal, K; Bien, P; Deanda, C; Pillar, CM; Prokocimer, P | 1 |
| Baruch, AM; Bhattacharyya, H; Biswas, P; Itani, KM; Reisman, A | 1 |
| Hodges, G; McCardle, JE; Young, MJ | 1 |
| Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
| Duttagupta, S; Itani, KM; Li, JZ; Weigelt, J | 1 |
| Stiefelhagen, P | 1 |
| Bush, LM; de Almeida, KN | 1 |
| Scheinfeld, N | 1 |
| Liu, LZ; McCollum, M; Sorensen, SV | 1 |
| Havlichek, DH; Missavage, A; Peloquin, CA; Schooley, S; Stein, GE | 1 |
| De Cock, E; Duttagupta, S; Resch, A; Schürmann, D; Sorensen, SV | 1 |
| Heymann, WR; Kil, EH; Weinberg, JM | 1 |
10 review(s) available for oxazolidin-2-one and Staphylococcal Skin Infections
| Article | Year |
|---|---|
Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections.
Topics: Administration, Intravenous; Administration, Oral; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Humans; Lipoglycopeptides; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Tetrazoles | 2019 |
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Europe; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Practice Guidelines as Topic; Risk Factors; Soft Tissue Infections; Staphylococcal Skin Infections | 2014 |
[Skin and soft tissue infections: current therapeutic options].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daptomycin; Humans; Linezolid; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Tigecycline; Time Factors; Treatment Outcome | 2008 |
Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
Topics: Acetamides; Cost-Benefit Analysis; Decision Support Techniques; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Risk Factors; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Randomized Controlled Trials as Topic; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2010 |
Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus in patients with and without vascular disease.
Topics: Acetamides; Administration, Oral; Aged; Anti-Bacterial Agents; Female; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Vascular Diseases | 2012 |
Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Health Care Costs; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2012 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
Methicillin-resistant Staphylococcus aureus: an update for the dermatologist, Part 3: Clinical management.
Topics: Acetamides; Algorithms; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcal Skin Infections; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
10 trial(s) available for oxazolidin-2-one and Staphylococcal Skin Infections
| Article | Year |
|---|---|
The impact of linezolid versus vancomycin on surgical interventions for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Chi-Square Distribution; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Oxazolidinones; Prospective Studies; Staphylococcal Skin Infections; Vancomycin | 2013 |
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cross Infection; Dose-Response Relationship, Drug; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2013 |
Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysis.
Topics: Acetamides; Aged; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Skin; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2014 |
Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections.
Topics: Acetamides; Adult; Amidohydrolases; Anti-Bacterial Agents; beta-Lactamases; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Resistance, Multiple, Bacterial; Female; Humans; Hydroxamic Acids; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Skin Infections; Treatment Outcome | 2014 |
Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials.
Topics: Acetamides; Anti-Bacterial Agents; Blood Platelets; Double-Blind Method; Drug Administration Schedule; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Platelet Count; Staphylococcal Skin Infections; Tetrazoles | 2014 |
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Skin Infections; Tetrazoles | 2015 |
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
Topics: Acetamides; Americas; Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Bacterial; Europe; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Oxazolidinones; Soft Tissue Infections; South Africa; Staphylococcal Skin Infections; Vancomycin | 2010 |
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2011 |
In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Culture Media; Double-Blind Method; Drug Administration Schedule; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin; Staphylococcal Skin Infections; Staphylococcus; Tetrazoles | 2012 |
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Americas; Anti-Bacterial Agents; Anti-Infective Agents; Asia; Europe; Female; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin; Methicillin Resistance; Middle Aged; New Zealand; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
22 other study(ies) available for oxazolidin-2-one and Staphylococcal Skin Infections
| Article | Year |
|---|---|
An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Biofilms; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus; Tetrazoles | 2018 |
In vitro activity of tedizolid and other comparator drugs in methicillin-resistant Staphylococcus aureus isolates in skin and soft tissue infections in seven Colombian hospitals
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colombia; Female; Hospitals; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Prospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Tetrazoles; Young Adult | 2018 |
Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Diabetes Mellitus, Experimental; Diabetic Foot; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Staphylococcal Skin Infections; Treatment Outcome | 2013 |
Disseminated staphylococcal disease in healthy children-experience from two tertiary care hospitals of West Bengal.
Topics: Acetamides; Adolescent; Anti-Infective Agents; Arthritis, Infectious; Child; Child, Preschool; Female; Humans; Immunocompetence; Linezolid; Magnetic Resonance Imaging; Male; Oxazolidinones; Risk Factors; Staphylococcal Skin Infections; Tomography, X-Ray Computed | 2014 |
Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Diterpenes; Female; Fusidic Acid; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Oxazolidinones; Staphylococcal Skin Infections; Vancomycin; Wound Infection | 2013 |
What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe?
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Soft Tissue Infections; Staphylococcal Skin Infections | 2014 |
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Europe; Female; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Patient Discharge; Practice Guidelines as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2014 |
Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
Topics: Acetamides; Acetaminophen; Analgesics; Anti-Infective Agents; Cellulitis; Diphenhydramine; Drug Combinations; Famotidine; Furosemide; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Oxycodone; Pulmonary Edema; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.
Topics: Acetamides; Aged; Anti-Infective Agents; Diabetic Foot; Female; Humans; Inflammation; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Permeability; Soft Tissue Infections; Staphylococcal Skin Infections | 2008 |
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2009 |
Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Decision Trees; Drug Monitoring; France; Gram-Positive Bacterial Infections; Humans; Inpatients; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections | 2009 |
Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Drug Utilization; Drug Utilization Review; Female; Humans; Inpatients; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Diabetes Complications; Diabetic Foot; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2011 |
Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Female; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Skin Infections; Tetrazoles; Thigh | 2012 |
Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clinical Trials, Phase IV as Topic; Female; Humans; Infusions, Intravenous; Linezolid; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Oxazolidinones; Propensity Score; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2012 |
Cost avoidance using linezolid for methicillin-resistant Staphylococcus aureus infections in a specialist diabetes foot clinic.
Topics: Acetamides; Diabetic Foot; Drug Utilization; Health Care Costs; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Skin Infections; Staphylococcus aureus; United Kingdom | 2012 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
[Is your patient MRSA (multi-resistent Staphylococcus aureus) free?].
Topics: Acetamides; Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Resistance, Multiple; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Patient Admission; Preoperative Care; Staphylococcal Skin Infections; Staphylococcus aureus | 2006 |
Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection.
Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2006 |
A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in
Topics: Acetamides; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; United States; Vancomycin | 2007 |
Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Diabetes Complications; Drug Resistance, Multiple, Bacterial; Female; Foot Diseases; Humans; Linezolid; Male; Methicillin Resistance; Microbial Viability; Middle Aged; Oxazolidinones; Peripheral Vascular Diseases; Serum; Serum Bactericidal Test; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Time Factors; Vancomycin Resistance | 2007 |
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Decision Support Techniques; Delphi Technique; Germany; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |